SLSNConsumer Defensive · Household & Personal Products

SLSN Stock Forecast: Solesence, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026

$0.81

−2.58% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 12 Sept 2026 — in the lower half.

Market cap

$57.1M

Ticker Nerd rank

31 / 100

Median analyst target

—

Analysts covering

—

Revenue$15.3M−24.7% y/y

Operating income$121K

Net income−$158K

Free cash flow−$278K

Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown

Total return, dividends reinvested

−6.0%

−20.7%

YTD

−49.5%

−76.1%

From 52W high

−81.5%

From 52W low

+26.3%

$0.64

$4.36

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

SLSN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Solesence, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026

31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals

Issuance

Size

Quality

Value

Revisions

Volatility

Growth

Momentum

Accruals (90): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (6): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SLSN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SLSN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SLSN appears on the weeks it earns a place.

Performance

SLSN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 11 Sept 2026, Solesence, Inc. returned −76.1% against +17.5% for the S&P 500, dividends included.

SLSN vs S&P 500, last 12 monthsTotal return, rebased to 100

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SLSN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Solesence, Inc. (SLSN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 88.6×
Price / sales: 1.0×
Price / book: 4.3×
EV / EBITDA: −85.5×

Growth & margins

Revenue growth (YoY): −24.7%
Earnings growth (YoY): −24.7%
Gross margin: 31.0%
Operating margin: 0.8%
Net margin: −5.3%

Returns & dividend

Return on equity: −18.6%
Return on assets: −2.4%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Solesence, Inc. (SLSN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

Solesence, Inc. has a market value of $57.1M and an enterprise value of $78.8M.
Revenue in the twelve months to 30 June 2026: $55.4M. The latest quarter shrank 24.7% year on year.
Net income over the same four quarters: −$1.9M, a −3.4% net margin.
Diluted earnings per share, trailing twelve months: $−0.03.
Free cash flow in the twelve months to 30 June 2026: −$849K.
Shares outstanding: 70.6M.
Trailing P/E: 88.6×.
Solesence, Inc. employs 115 people — $481K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 12 Sept 2026

Data provided by Twelve Data

Peers

SLSN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products

Company	Market cap	TKN rank
SLSNSolesence, Inc.	$57.1M	31
GROVGrove Collaborative Holdings, Inc.	$42.4M	91
SKINSkinhealth Systems, Inc.	$89.4M	76
UGUnited-Guardian, Inc.	$32.9M	91
DSYBig Tree Cloud Holdings Ltd.	$31.1M	4
WALDWaldencast plc	$171.3M	55
ATTTAtlas Trinity Tech Ltd.	$17.4M	9

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Solesence, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SLSN news & analysis

SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt

Zacks Investment Research · 25 Aug 2026neutral

Solesence reported break-even earnings for the second quarter, though results were pressured by higher operating expenses. Improving production efficiency and expectations for a stronger second half were cited as favorable factors.

Why it matters — SLSN watchers would care because the company's ability to manage rising costs while showing improved production efficiency signals how it may fare in the second half of the year.

Solesence, Inc. (SLSN) Q2 2026 Earnings Call Transcript

Seeking Alpha · 20 Aug 2026neutral

Solesence, Inc. published the transcript of its Q2 2026 earnings call. The item, sourced from Seeking Alpha, is a record of the company's quarterly earnings presentation.

Why it matters — SLSN watchers would look to this transcript for direct commentary from company leadership on its second-quarter 2026 results and outlook.

Solésence Reports Second Quarter 2026 Financial Results

GlobeNewsWire · 19 Aug 2026neutral

Solésence, Inc. reported its financial results for the second quarter of 2026. The release includes contact information and instructions for confirming the details and distribution of the announcement.

Why it matters — A SLSN watcher would care because the company's quarterly financial results provide an update on its recent performance.

Solésence To Report Second Quarter 2026 Financial Results and Host a Conference Call on August 11

GlobeNewsWire · 28 July 2026neutral

Solésence, Inc. announced it will report second quarter 2026 financial results before the market opens on August 11, 2026, and will host a conference call and webcast the same day.

Why it matters — The announcement provides the date and time for SLSN's next quarterly earnings release and investor call, which will disclose the company's financial performance for the period.

FAQ

Frequently asked questions about SLSN stock

How does Ticker Nerd's model rank SLSN?

As at 12 Sept 2026, Solesence, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (90 of 100).

What is the SLSN stock forecast for 2030?

No analyst covering Solesence, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SLSN are extrapolating price history, which says nothing about the business.

How has SLSN stock performed over the past year?

Solesence, Inc. returned -76.1% over the 12 months to 11 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Solesence, Inc. do?

Solesence Inc. is a science-driven healthcare and personal care company focused on beauty and life science applications.

What is the latest news on SLSN?

The most recent item we track (Zacks Investment Research, 25 Aug 2026): "SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt". Solesence reported break-even earnings for the second quarter, though results were pressured by higher operating expenses. Improving production efficiency and expectations for a stronger second half were cited as favorable factors.

Company

About Solesence, Inc.

Solesence Inc. is a science-driven healthcare and personal care company focused on beauty and life science applications. It develops and manufactures engineered materials, formulation technologies, and finished products centered on mineral-based skin health. The company’s offerings include surface-engineered zinc oxide and titanium dioxide ingredients, proprietary active ingredients for UV protection, and fully formulated skincare and color cosmetics products such as sunscreens and daily care items. Solesence also provides commercial manufacturing and formulation development services, supporting brands that seek mineral-based solutions with improved transparency, wearability, and aesthetic performance. Based in Romeoville, Illinois, Solesence serves a range of consumer and professional markets across skincare, cosmetics, and related life science uses.

CEO Mr. Kevin Cureton · 115 employees · United States · https://solesence.com